More recently, CD19 exon 3 point mutations in a case of high grade B-cell lymphoma were found to confer resistance to certain subsets of auto-CAR populations while retaining sensitivity to others (69). The gene discussed is CD19; the disease is B-cell non-Hodgkin lymphoma.